NOTE 20.       STOCK-BASED COMPENSATION

SUMMARY OF STOCK-BASED COMPENSATION

A summary of share activity for all equity classified stock compensation during the year ended December 31, 2025, is presented below.

Type of Award

  ​ ​ ​

Shares Outstanding at 1/1/2025

  ​ ​ ​

Granted Shares

Vested / Exercised Shares

Expired Shares

Forfeited Shares

  ​ ​ ​

Shares Outstanding at 12/31/2025

Equity Classified - Performance Share Awards - Peer Group Market Condition Vesting

208,003

110,270

(55,386)

262,887

Equity Classified - Three Year Vest Restricted Shares

197,794

117,739

(112,009)

(272)

203,252

Total Shares

405,797

228,009

(167,395)

(272)

466,139

Amounts recognized in the financial statements for stock-based compensation are as follows (in thousands):

Year Ended December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Total Cost of Share-Based Plans Charged Against Income

$

4,158

$

3,637

$

3,673

EQUITY-CLASSIFIED STOCK COMPENSATION

Performance Share Awards – Peer Group Market Condition Vesting

Performance shares have been granted to certain employees under the 2010 Plan. The performance share awards entitle the recipient to receive, upon the vesting thereof, shares of common stock of the Company equal to between 0% and 150% of the number of performance shares awarded. The number of shares of common stock ultimately received by the award recipient is determined based on the Company’s total stockholder return as compared to the total stockholder return of a certain peer group during a three-year performance period. The Company granted a total of 110,270 performance shares during the year ended December 31, 2025.

The Company used a Monte Carlo simulation pricing model to determine the fair value of its awards that are based on market conditions. The determination of the fair value of market condition-based awards is affected by the Company’s stock price as well as assumptions regarding a number of other variables. These variables include expected stock price volatility over the requisite performance term of the awards, the relative performance of the Company’s stock price and stockholder returns to companies in its peer group, annual dividends, and a risk-free interest rate assumption. Compensation cost is recognized regardless of the achievement of the market conditions, provided the requisite three-year service period is met.

As of December 31, 2025, there was $1.9 million of unrecognized compensation cost, adjusted for estimated forfeitures, related to the outstanding performance share awards, which will be recognized over a remaining weighted average period of 1.8 years.

A summary of the activity for these awards during the years ended December 31, 2025, 2024, and 2023 is presented below: 

Performance Shares With Market Conditions

  ​ ​ ​

Shares

Wtd. Avg. Fair Value Per Share

Non-Vested at January 1, 2023

230,247

$

16.85

Granted

88,754

$

18.10

Vested

(72,141)

$

14.17

Expired

Forfeited

(9,485)

$

18.10

Non-Vested at December 31, 2023

237,375

$

18.08

Granted

100,391

$

15.28

Vested

(85,938)

$

15.99

Expired

Forfeited

(43,825)

$

17.67

Non-Vested at December 31, 2024

208,003

$

17.68

Granted

110,270

$

20.68

Vested

(55,386)

$

20.76

Expired

Forfeited

Non-Vested at December 31, 2025

262,887

$

18.29

Three Year Vest Restricted Shares

Restricted shares have been granted to certain employees under the 2010 Plan. Certain of the restricted shares vest on each of the first, second, and third anniversaries of January 28 of the applicable year provided the grantee is an employee of the Company on those dates. In addition, any unvested portion of the restricted shares will vest upon a change in control. Certain other restricted share awards, granted on July 1, 2022, vested entirely on the third anniversary of the grant date, or July 1, 2025. The Company granted a total of 117,739 shares of restricted Company common stock during the year ended December 31, 2025.

During the years ended December 31, 2025, 2024, and 2023 the Company’s determination of the fair value of the three-year vest restricted stock awards was calculated by multiplying the number of shares issued by the Company’s stock price at the grant date. Compensation cost is recognized on a straight-line basis over the applicable vesting period.

As of December 31, 2025, there was $2.2 million of unrecognized compensation cost, adjusted for estimated forfeitures, related to the three-year vest non-vested restricted shares, which will be recognized over a remaining weighted average period of 1.8 years.

A summary of the activity for these awards during the years ended December 31, 2025, 2024, and 2023 is presented below: 

Non-Vested Restricted Shares

  ​ ​ ​

Shares

  ​ ​ ​

Wtd. Avg. Fair Value Per Share

Non-Vested at January 1, 2023

212,079

$

17.97

Granted

96,453

$

19.12

Vested

(74,229)

$

16.00

Expired

Forfeited

(17,946)

$

19.08

Non-Vested at December 31, 2023

216,357

$

19.07

Granted

108,391

$

16.31

Vested

(75,434)

$

17.80

Expired

Forfeited

(51,520)

$

18.76

Non-Vested at December 31, 2024

197,794

$

18.12

Granted

117,739

$

20.39

Vested

(112,009)

$

18.86

Expired

Forfeited

(272)

$

17.06

Non-Vested at December 31, 2025

203,252

$

19.02

NON-EMPLOYEE DIRECTOR STOCK COMPENSATION

Each member of the Company’s Board of Directors has the option to receive his or her annual retainer and meeting fees in shares of Company common stock rather than cash. The number of shares awarded to the directors making such election is calculated quarterly by dividing (i) the sum of (A) the amount of the quarterly retainer payment due to such director plus (B) meeting fees earned by such director during the quarter, by (ii) the trailing 20-day average price of the Company’s common stock as of the last day of the quarter, rounded down to the nearest whole number of shares.

Each non-employee director serving as of the beginning of each calendar year shall receive an annual award of the Company’s common stock. The value of such award totaled $62,500 for the years ended December 31, 2025 and 2024, and $35,000 for the year ended December 31, 2023 (the “Annual Award”). The number of shares awarded is calculated based on the trailing 20-day average price of the Company’s common stock as of the date two business days prior to the date of the award, rounded down to the nearest whole number of shares. Commencing in 2021, non-employee directors no longer receive meeting fees, but receive additional retainers for service on Board committees, as set forth in the Company’s Non-Employee Director Compensation Policy available on the Company’s website (www.ctoreit.com).

During the years ended December 31, 2025, 2024, and 2023, the expense recognized for the value of the Company’s common stock received by non-employee directors totaled $0.7 million, or 33,466 shares, $0.7 million or 38,068 shares, and $0.4 million or 25,147 shares, respectively. The expense recognized during the years ended December 31, 2025, 2024, and 2023 includes the Annual Award received during the first quarter of each year.

Historical Timeline

Fiscal YearFiled
2025Feb 19, 2026Showing above
2024Feb 20, 2025
2023Feb 22, 2024
2022Feb 23, 2023
2021Feb 24, 2022
2020Mar 5, 2021
2019Mar 6, 2020
2016Feb 24, 2017

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.